
Founded in 2022, AIATELLA is revolutionizing cardiovascular care by addressing the global healthcare crisis of increasing imaging volumes and specialist shortages through AI-powered automation. Their solutions enhance the speed and accuracy of cardiovascular diagnostics, enabling healthcare providers to deliver timely and effective patient care. With a focus on preventative care, AIATELLA's technology allows for early detection of cardiovascular diseases, ultimately improving patient outcomes and reducing the burden on healthcare systems.

Founded in 2022, AIATELLA is revolutionizing cardiovascular care by addressing the global healthcare crisis of increasing imaging volumes and specialist shortages through AI-powered automation. Their solutions enhance the speed and accuracy of cardiovascular diagnostics, enabling healthcare providers to deliver timely and effective patient care. With a focus on preventative care, AIATELLA's technology allows for early detection of cardiovascular diseases, ultimately improving patient outcomes and reducing the burden on healthcare systems.
Founded: 2022 (Helsinki, Finland)
Headcount: ~9 employees
Product: AI platform for automated cardiovascular image analysis across MRI, CT, and ultrasound
Business model: B2B SaaS targeting hospitals and imaging providers
Recent funding: Seed M (announced Jun 4, 2025), led by Nordic Science Investments
Cardiovascular imaging and diagnostics
2022
Medical devices / Healthtech / Medical imaging
2,000,000 EUR
Participants included Specialist VC, Harjavalta Ventures, Business Finland and angel investors
“Seed led by a regional specialist VC (Nordic Science Investments) with public innovation agency participation (Business Finland)”